Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Bittium Corporation’s Financial Calendar for 2021

Stock exchange release Free for publication on December 15, 2020 at 9.00 am (CET+1) Bittium Corporation’s Financial Calendar for 2021 Bittium Corporation will publish financial reports from the first half of the year (Half Year Financial Report) and from the whole fiscal year (Financial Statement Bulletin). In addition, the company will publish Business Reviews from the financial periods of January-March and January-September. The structure of the Business Reviews is lighter than that of the financial reports. In 2021, Bittium Corporation will publish its Half Year Financial

Digia acquires Climber International AB, a consulting firm specialising in business analytics, along with its subsidiaries, and bolsters its position as a provider of data-driven services

Digia PlcInsider information15 December 2020 at 9:00On 15 December 2020, Digia Plc and Climber International AB have signed an agreement whereby Digia Plc will acquire the entire share capital of the Swedish company Climber International AB. It is planned that the acquisition will be implemented on 7 January 2021. After the acquisition, Digia will have more than 300 data integration and business analytics professionals as part of their organisation. Climber International AB is a Swedish company that provides consulting and solutions for the development of data-driven business. Its

Outokumpu upgrades its guidance for the fourth quarter

Outokumpu OyjInside informationDecember 15, 2020 at 9.00 am EETOutokumpu upgrades its guidance for the fourth quarter Outokumpu upgrades its guidance for the fourth quarter of 2020 as the adjusted EBITDA is expected to be higher compared to the third quarter. Stainless steel deliveries are estimated to increase by approximately 5-10% due to stronger than expected market recovery. The result is also expected to be supported by improved cost efficiency and positive raw material impacts. The company had earlier expected its fourth-quarter adjusted EBITDA to remain at the same level

Vicore Pharma announces Last Patient Last Visit in the mechanistic phase II study with C21 in systemic sclerosis

Gothenburg, December 15, 2020 – Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for serious lung disorders, today announces that the last patient has completed the final visit in the mechanistic phase II study of Raynaud’s phenomenon in systemic sclerosis patients.· The study has been closed with 12 patients having completed the study · Top line data is estimated to be available in February 2021 “After reassuring that the statistical power is sufficient to pick up the signal we are looking for in the study, we decided to stop

Stora Enso shares converted

STORA ENSO OYJ STOCK EXCHANGE RELEASE 15 December 2020 at 9.00 EETDuring the 1 November 2020 – 30 November 2020 conversion period there was one conversion and a total of 8 A shares were converted into R shares. The shares were recorded in the Finnish trade register today, 15 December 2020, and trading in the new R shares will start on 16 December 2020.Breakdown of shares after conversion: A shares 176 254 415R shares 612 365 572Total 788 619 987 Each A share and each ten R shares carry one vote. The total amount of votes after the conversion is at least 237 490 972.For

KEY INFORMATION RELATING TO THE SUBSEQUENT OFFERING

Reference is made to the announcement by Saga Pure ASA on 14 December 2020 concerning a private placement with total gross proceeds of NOK 73.5 million and a contemplated subsequent offering (the "Subsequent Offering"). Date on which the terms of the Subsequent Offering was announced: 14 December 2020Last day including right: 14 December 2020First day excluding right: 15 December 2020Record date: 16 December 2020Board resolution date: Not yet determinedMaximum number of new shares: 4,000,000Subscription price: NOK 2.10Shall the rights be listed: No Launch of the

Gradientech Announces Prominent International Scientific Advisory Board

Swedish diagnostics firm Gradientech is proud to announce the appointment of three internationally renowned members to the company’s scientific advisory board, SAB. With their expertise in clinical microbiology, the new advisors will provide valuable support in preparing for a successful market launch of Gradientech’s in vitro diagnostic system for ultra-rapid antibiotic susceptibility testing, claimed to be the fastest among new systems in development.“To significantly shorten the time to an AST result is of tremendous importance to the patient and the clinical colleague in charge!

1,000 square meters of solar cells for Kallebäcks Terrasser

Kallebäcks Terrasser’s large new office building will be self-sufficient in renewable energy. Save by Solar will now install 508 solar cell modules on the roof of the property. Internally-produced wind power together with 1,000 square meters of solar cell modules will contribute to a climate-smart everyday life for the commercial tenants that are moving in at the end of next year. The solar cell production will also generate locally produced electricity for the charging stations in the property’s garage.In one year, the approximately 250 meter long office building in Kallebäcks Terrasser

Jan Bardell appointed acting CEO of Climeon

The Board of Directors of Climeon has appointed Jan Bardell acting CEO of Climeon until the recruitment of a permanent CEO has been completed. Jan Bardell has long and solid experience as CEO and leader within the energy industry. The Board of Directors of Climeon has initiated the recruitment of a new CEO to lead the company in the next phase. Until the recruitment has been completed, Jan Bardell has been appointed acting CEO. He takes office immediately. Jan Bardell has long and solid experience as CEO and leader in the energy industry, including as CEO of One Nordic AB and before

Ascelia Pharma gets US patent for second generation Mangoral

Ascelia Pharma AB (publ) (ticker: ACE) today announced that the US Patent Office (USPTO) has issued a new patent covering a second-generation formulation of lead drug candidate Mangoral, currently in the pivotal Phase 3 study SPARKLE. The new patent further improves the unique value proposition of the Mangoral franchise and provides patent protection until year 2040 in the US.The opportunity to improve the Mangoral product and add patent protection rights add significant value to Ascelia Pharma’s Mangoral franchise. With the new patent, the protection rights are further strengthened until

City dwellers are slightly less concerned about climate change during the COVID-19 pandemic

YIT Corporation Press release, December 15, 2020, at 08:00 a.m.65% of Finnish city dwellers are worried about climate change. Of the Sustainable Urban Environments Barometer 2020 respondents, 15% were very worried, 20% were worried and 30% were fairly worried about climate change. Of the respondents, 25% were only slightly worried and 10% were not at all worried – in other words, a total of 35% of city dwellers. Last year, the corresponding total figures were 68% and 32%, respectively. In other words, city dwellers are slightly less concerned about climate change than they have been.

Intelligent connected machines to be a major part of life by 2030, consumers predict

· Early tech-adopter consumers predict intelligent connectivity to enable services that go way beyond the mobile broadband experiences of today · Consumer expectations on smarter connectivity are higher than for any other connected intelligent machine type · Predictions in the latest Ericsson ConsumerLab report, point to opportunities for 5G service providers for new intelligent network servicesConsumers expect connected technology to become more flexible and interactive going forward and see devices enabling more proactive, and even creative choices in a wide range of everyday life

SDRL - Seadrill Announces Expiry of Forbearance Agreements

Hamilton, Bermuda, 14 December 2020 – Reference is made to the announcements by Seadrill Limited ("Seadrill" or the "Company") (OSE:SDRL, OTCQX:SDRLF) on 20 November 2020 regarding forbearance agreements entered into by the Company with certain creditors in respect of the group's senior secured credit facility agreements and leasing arrangements. The term of the forbearance agreements expired on 14 December 2020, and, accordingly, the creditors with whom forbearance agreements were entered into are no longer prevented from taking actions in respect of events of default that may arise

Saga Pure ASA: Mandatory Notification of Trade

Reference is made to the stock exchange notice from Saga Pure ASA (the "Company") dated 14 December 2020 regarding completion of a private placement of new shares in the Company (the "Private Placement"). Martin Nes, chairman and primary insider, has on 14 December 2020 been allocated 150,000 shares in the Company in the Private Placement at a price of NOK 2.10 per share through his controlled company Hanekamb Invest AS. After the transaction, Martin Nes and associated companies have a holding of 2,000,000 shares in the Company. This information is subject to the disclosure

Saga Pure ASA: Mandatory Notification of Trade

Reference is made to the stock exchange notice from Saga Pure ASA (the "Company") dated 14 December 2020 regarding completion of a private placement of new shares in the Company (the "Private Placement"). Bjørn Simonsen, CEO and primary insider, has on 14 December 2020 been allocated 952,000 shares in the Company in the Private Placement at a price of NOK 2.10 through his controlled company Simonsen Invest AS. After the transaction, Bjørn Simonsen and associated companies have a holding of 17,618,667 shares in the Company and 15,000,000 share options, each giving the right to acquire one

Saga Pure ASA: Mandatory Notification of Trade

Reference is made to the stock exchange notice from Saga Pure ASA (the "Company") dated 14 December 2020 regarding completion of a private placement of new shares in the Company (the "Private Placement"). Espen Lundaas, CFO and primary insider, has on 14 December 2020 been allocated 150,000 shares in the Company in the Private Placement at a price of NOK 2.10 per share through his controlled company EL Investment AS. After the transaction, Espen Lundaas and associated companies have a holding of 2,000,000 shares in the Company. This information is subject to the disclosure

Saga Pure ASA: Mandatory Notification of Trade – Disclosure of large shareholding

Reference is made to the stock exchange notice from Saga Pure ASA (the "Company") dated 14 December 2020 regarding completion of a private placement of new shares in the Company (the "Private Placement"). Øystein Stray Spetalen, director and primary insider, has on 14 December 2020 been allocated 4,762,000 shares in the Company in the Private Placement at a price of NOK 2.10 per share through his controlled company Tycoon Industrier AS. After the transaction, Øystein Stray Spetalen and associated companies have a holding of 195,391,799 shares in the Company. As a consequence of this

Saga Pure ASA - Private placement successfully completed

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Oslo, 14 December 2020. Reference is made to the stock exchange release from Saga Pure ASA ("SAGA " or the "Company") published on 14 December 2020 regarding a contemplated private placement (the "Private Placement"). The Company is pleased to announce that it has raised NOK 73.5 million in gross proceeds through the Private Placement of 35,000,000 new

Invent Medic will launch Efemia bladder support in Spain with its new regional partner En Suelo Firme

Invent Medic announces that the company has signed a distribution agreement with Madrid-based En Suelo Firme, a company specialized in offering pelvic floor health products to Spanish-speaking women in Europe. En Suelo Firme has a strong social media presence, with more than 250,000 followers and over 4 million annual website visitors.With this distribution agreement for Spain, Invent Medic is extending its outreach for Efemia to eight European markets. The company is already reaching healthcare entities and users in Sweden, Norway, Denmark, the UK, Germany, the Netherlands and Belgium.

Grant of incentive warrants to CEO and the Board of Directors

The Board of Directors of Cessatech A/S ("Cessatech" or the “Company”) has decided on the final terms for the warrant program, in accordance with what has been earlier communicated in the IPO prospectus. In total 334,800 warrants are granted to the CEO and the Board of Directors. The background for the implementation of the warrant program is to create possibilities for Cessatech to retain and incentivize the Board of Directors and the CEO by offering a long-term ownership engagement, which will contribute to an alignment of interests between the warrant holders and the shareholders and

New Jersey Posts $931,620,415 Sports Handle for November

Iselin, New Jersey - World Sports Network, reports that the New Jersey Division of Gaming enforcement has released their handle  for the month of November posting an all time high for the fourth month in a row.“Having now experienced three consecutive all time highs there is beginning to creep in speculation as to when the boom will bust. Confronted with the holidays, a time when most consumers have less free cash on hand, it is possible that the continual rise will be dampened.” - Ioana Romanasu, Editor at WSN.

Scandinavian Biogas carries out a SEK 586 million private placement of dark green shares and publishes a company description in connection with the listing

THIS PRESS RELEASE IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES IN ACCORDANCE WITH APPLICABLE LAW. PLEASE REFER TO "IMPORTANT INFORMATION" AT THE END OF THE PRESS RELEASE.Scandinavian Biogas Fuels International AB (publ) (“Scandinavian Biogas” or the “Company”), a

Data-driven discovery of biomarkers pave way for improved diagnosis of contact allergy

With the help of algorithms, researchers at Karolinska Institutet in Sweden have identified markers that can differentiate between irritant eczema and contact allergy, two skin reactions that look similar but require different treatment. Their findings, which are published in the journal Proceedings of the National Academy of Sciences (PNAS), support the further development of an alternative to today’s diagnostic patch tests.About 20 percent of the population of high-income countries are troubled by contact eczema, a disease often associated with exposure to chemicals in the working

There are no items matching the current filter
There are no more items matching the current filter
Back to top